Hypoxia-induced cysteine metabolism reprogramming is crucial for the tumorigenesis of colorectal cancer
Redox Biology · 2024-09 · 75 · 103286
DOI: 10.1016/j.redox.2024.103286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2024-09. Verfasst von Zhang Lin und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Biomedical Engineering, School of Medicine,…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cysteine, Metabolic Reprogramming. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Metabolic reprogramming is a hallmark of human cancer, and cancer-specific metabolism provides opportunities for cancer diagnosis, prognosis, and treatment. However, the underlying mechanisms by which metabolic pathways affect the initiation and progression of colorectal cancer (CRC) remain largely unknown. Here, we demonstrate that cysteine is highly enriched in colorectal tumors compared to adjacent non-tumor tissues, thereby promoting tumorigenesis of CRC. Synchronously importing both cysteine and cystine in colorectal cancer cells is necessary to maintain intracellular cysteine levels. Hypoxia-induced reactive oxygen species (ROS) and ER stress regulate the co-upregulation of genes encoding cystine transporters (SLC7A11, SLC3A2) and genes encoding cysteine transporters (SLC1A4, SLC1A5) through the transcription factor ATF4. Furthermore, the metabolic flux from cysteine to reduced glutathione (GSH), which is critical to support CRC growth, is increased due to overexpression of glutathione synthetase GSS in CRC. Depletion of cystine/cysteine by recombinant cyst(e)inase effectively inhibits the growth of colorectal tumors by inducing autophagy in colorectal cancer cells through mTOR-ULK signaling axis. This study demonstrates the underlying mechanisms of cysteine metabolism in tumorigenesis of CRC, and evaluates the potential of cysteine metabolism as a biomarker or a therapeutic target for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Biomedical Engineering, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, China.
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Biomedical Engineering, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, China; Department of…
- Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha, 410081, China.
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Biomedical Engineering, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, China. Electronic ad…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lin, Z., Yang, S., Qiu, Q., Cui, G., Zhang, Y., Yao, M., Li, X., Chen, C., Gu, J., Wang, T., Yin, P., Sun, L., & Hao, Y. (2024). Hypoxia-induced cysteine metabolism reprogramming is crucial for the tumorigenesis of colorectal cancer. Redox Biology, 75, 103286. https://doi.org/10.1016/j.redox.2024.103286
Vancouver
Lin Z, Yang S, Qiu Q, Cui G, Zhang Y, Yao M, et al. Hypoxia-induced cysteine metabolism reprogramming is crucial for the tumorigenesis of colorectal cancer. Redox Biology. 2024;75:103286. doi:10.1016/j.redox.2024.103286
BibTeX
@article{Lin2024,
author = {Lin, Zhang and Yang, Shiyi and Qiu, Qianqian and Cui, Gaoping and Zhang, Yanhua and Yao, Meilian and Li, Xiangyu and Chen, Chengkun and Gu, Jun and Wang, Ting and Yin, Peng and Sun, Longci and Hao, Yujun},
title = {Hypoxia-induced cysteine metabolism reprogramming is crucial for the tumorigenesis of colorectal cancer},
journal = {Redox Biology},
year = {2024},
volume = {75},
pages = {103286},
doi = {10.1016/j.redox.2024.103286}
}
EUVIMED